ALFA Finder| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 4.5 | 4.0 | 3.1 |
| Other income | 0.3 | 0.0 | 0.1 |
| Total income | 4.8 | 4.0 | 3.2 |
| Profit before exceptional items & tax | -0.5 | -0.2 | 0.0 |
| Profit before tax | -0.5 | -0.2 | 0.0 |
| Net profit | -0.5 | -0.2 | 0.0 |
| Operating margin | -10.4% | -5.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +45.20% |
|---|
BSE results filing, BSE: 544312. Figures extracted from the filing.
Hamps Bio Ltd: key numbers
- Share price
- ₹25.50
- Market cap
- ₹22.22 Cr
- Revenue (annual)
- ₹8.47 Cr
- Net profit (annual)
- ₹-0.74 Cr
- P/E (TTM)
- -30.1×Sector 29.0×
- Promoter holding
- 71.99%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hamps Bio Ltd
All →Hamps Bio H1 FY27 Results: Turns Profitable, Net Profit ₹0.2 Cr
Hamps Bio Ltd reported revenue from operations of ₹7.3 Cr (+82.5% YoY) and net profit of ₹0.2 Cr for H1 FY27.
- Key figure
- Net profit ₹0.2 Cr
Hamps Bio Board Meeting Date
Hamps Bio Limited has given prior intimation of a board meeting on November 6, 2026. The board will consider unaudited standalone and consolidated results for the half year ended September 30, 2026.
Hamps Bio Other Announcement
Hamps Bio Ltd submitted a Regulation 74(5) certificate from its RTA. The certificate confirms the company's shares are held entirely in demat form.
Hamps Bio Board Meeting Outcome
Hamps Bio Ltd announced the board meeting outcome, approving revised remuneration for its Chairman & Managing Director, Whole Time Director, CFO, and a Director.
Hamps Bio Annual General Meeting
Hamps Bio Ltd held its 19th Annual General Meeting on September 09, 2026, where shareholders transacted the businesses mentioned in the AGM notice.
Hamps Bio Annual Report
Hamps Bio Ltd has submitted its Annual Report for the financial year 2025-26. The report includes the notice of the 19th Annual General Meeting.